BACKGROUND AND PURPOSE: The beneficial effects of treatment and rehabilitation of @entity1 with @entity64 in a dedicated @entity64 unit (SU) are well established. We wanted to examine if these effects are limited to certain groups of @entity1 or if they apply to all @entity1 independent of age, sex, comorbidity, and initial @entity64 severity. METHODS: This was a community-based study of outcome in 1241 consecutive @entity64 @entity1 from 2 communities in Copenhagen: In one (Frederiksberg), treatment and rehabilitation were given in general neurological and medical wards (GW), and in the other (Bispebjerg) in one single large SU. Outcome measures were initial, 1-year, and 5-year mortality rates, a poor outcome ( @entity204 or discharge to a nursing home), and length of hospital stay (LOHS). Multivariate regression analyses were used to examine the independent effect of SU treatment on the various subgroups. RESULTS: The relative risks of @entity204 , poor outcome, and 1-year and 5-year mortality rates were reduced by 40% on average in @entity1 treated in the SU compared with the GW. A beneficial effect of SU treatment was observed regardless of the @entity1 's age, sex, comorbidity, and initial @entity64 severity. Those who benefited most appeared to be the @entity1 with the most severe @entity64 (poor outcome: OR 0.17; 95% CI 0.05 to 0.58). Those who benefited least were @entity1 with mild or moderate @entity64 (poor outcome: OR 0.66; 95% CI 0.41 to 0.98) and @entity1 <75 years of age (poor outcome: OR 0.66; 95% CI 0.36 to 1.19). LOHS was reduced by 2 to 3 weeks in all who had their treatment in the SU except in @entity1 with the most severe @entity64 . LOHS in these @entity1 was similar to LOHS in the GW. CONCLUSIONS: A beneficial effect of treatment in a SU is achieved in completely unselected @entity1 independent of their age, sex, comorbidity, and @entity64 severity. Those who had the most severe @entity64 appeared to benefit most. All @entity1 with @entity64 should therefore have access to treatment and rehabilitation in a dedicated SU.

Who benefits from treatment and rehabilitation in a XXXX Unit? A community-based study.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity64 :: ('MESH:D020521', 'Disease') :: ['strokes', 'stroke', 'acute stroke'] @entity204 :: ('MESH:D003643', 'Disease') :: ['initial death']
@entity64 :: (MESH:D020521,Disease) :: ['stroke']
